Unihealth Hospitals deploys Rs 54.7632 crore of IPO funds
Key highlights
- Unihealth Hospitals utilised Rs 54.7632 crore of Rs 56.5488 crore in IPO proceeds by September 30, 2026.
- Rs 1.697 crore remained allocated to UMC Global Health Limited’s Nigerian capital-expenditure expansion.
- Shareholders approved a Rs 13.50 crore reallocation to India and Mauritius on June 26, 2024.
- Uganda generated Rs 64.2709 crore of segment revenue in the half year ended September 30, 2026.
powered by IRIS

Unihealth Hospitals Limited had utilised Rs 54.7632 crore of its Rs 56.5488 crore initial public offering proceeds by September 30, 2026, leaving Rs 1.697 crore allocated to Nigerian subsidiary UMC Global Health Limited’s proposed capital-expenditure expansion. G. P. Kapadia & Co. certified the utilisation and said the unutilised amount was maintained in company bank accounts.
Know Unihealth Hospitals inside out
Results, valuation, peers and who's buying, in one view.
How much of Unihealth Hospitals’ IPO proceeds had been used?
Unihealth Hospitals had used Rs 54.7632 crore, or all but Rs 1.697 crore, of the Rs 56.5488 crore gross IPO proceeds as of September 30, 2026. The statutory auditor’s certificate dated November 14, 2026 reports the remaining balance only against UMC Global Health Limited, the Nigerian subsidiary.
The reported gross proceeds included Rs 8.143 crore of issue expenses, which were netted off to arrive at net IPO proceeds of Rs 48.4058 crore under the offer document. The utilisation certificate nevertheless records the gross proceeds and issue expenses in its total of Rs 56.5488 crore, alongside the spending or allocation for the operating objects.
Unihealth Hospitals stated in its Regulation 32 disclosure that there was no deviation or variation in IPO-proceeds utilisation during the half year ended September 30, 2026. The filing was dated November 14, 2026, when the Audit Committee approved the attached auditor certificate; it also recorded no comments from the Audit Committee or auditors on deviation or variation.
Where did Unihealth Hospitals deploy its IPO proceeds?
Unihealth Hospitals deployed Rs 17.00 crore in Victoria Hospital Limited, its joint venture in Kampala, Uganda, for proposed expansion capital expenditure and working-capital requirements. This was the largest original IPO object, and the full allocation had been utilised by September 30, 2026.
Unihealth Hospitals used Rs 2.903 crore of the Rs 4.60 crore allocated to UMC Global Health Limited for its Nigerian expansion. The Rs 1.697 crore balance was therefore neither a general-corporate-purpose nor issue-expense balance, and the parent company said it had retained required bank balances equal to its unutilised IPO proceeds at September 30, 2026.
A Nigeria-based accountant separately certified that UMC Global Health Limited had received and fully used USD 343,740 for capital expenditure by September 30, 2026. The subsidiary received five transfers, including USD 200,000 on November 7, 2024 and USD 10,000 on November 3, 2025, while the parent-level certificate shows the Rs 1.697 crore portion of the wider Nigerian allocation had not yet been transferred or used.
Biohealth Limited in Tanzania received and fully used USD 278,000 for expansion capital expenditure by September 30, 2026. Its certificate identifies USD 200,000 transferred on July 15, 2024 and USD 78,000 on March 20, 2025, with no unutilised balance at the Tanzanian subsidiary.
Got a follow-up? Ask IRIS
Why did Unihealth Hospitals reallocate the Tanzania IPO object?
Unihealth Hospitals reduced Biohealth Limited’s allocation from Rs 15.875 crore to Rs 2.375 crore and reallocated Rs 13.50 crore to subsidiaries in India and Mauritius. Shareholders approved the altered object through a special resolution passed by postal ballot on June 26, 2024, according to the IPO-proceeds disclosure.
The Rs 13.50 crore modified object covered investment in UMC Hospitals Private Limited in India and Unihealth Holdings Limited in Mauritius to support expansion and acquisition of projects across India and Africa. The parent-level utilisation certificate reports the entire Rs 13.50 crore as utilised by September 30, 2026.
A separate G. P. Kapadia & Co. certificate says UMC Hospitals received and fully used Rs 9.265 crore for expansion and acquisition projects by September 30, 2026. This comprised Rs 15.20 lakh invested in equity on July 5, 2024, Rs 7.448 crore invested through a rights issue on December 9, 2024, and a Rs 1.665 crore loan during the year.
Unihealth Holdings received USD 500,000 on September 4, 2024 for medical and healthcare investments, according to its Mauritius auditor. The Mauritius certificate reports USD 457,000 utilised and USD 43,000 unutilised by September 30, 2026, while the parent’s consolidated IPO certificate records the Rs 13.50 crore India-and-Mauritius allocation as utilised.
What do Unihealth Hospitals’ latest segments show?
Unihealth Hospitals reported total segment revenue of Rs 82.3378 crore for the half year ended September 30, 2026, compared with Rs 72.7304 crore for the half year ended September 30, 2025. Uganda contributed Rs 64.2709 crore in the latest period, making it the largest reported market, followed by India at Rs 15.5006 crore.
Uganda’s revenue rose from Rs 63.2431 crore a year earlier, while India’s revenue increased from Rs 8.9886 crore. Nigeria’s revenue increased from Rs 10.06 lakh to Rs 15.12 lakh, Tanzania’s increased from Rs 25.40 lakh to Rs 41.67 lakh, and Mauritius declined from Rs 1.441 crore to Rs 1.3199 crore; the United Arab Emirates reported Rs 61.85 lakh after reporting no revenue in the prior-year half.
Total segment profit before tax declined to Rs 18.3386 crore in the half year ended September 30, 2026 from Rs 29.5872 crore a year earlier. Uganda recorded Rs 23.8552 crore of profit before tax, India reported a Rs 33.07 lakh loss, Tanzania a Rs 5.41 lakh loss, and Nigeria reported Rs 4,000 of profit before tax versus a Rs 47.90 lakh loss in the prior-year half.
Conclusion
Unihealth Hospitals had deployed almost all of its IPO proceeds by September 30, 2026, with Rs 54.7632 crore used across Uganda, Nigeria, Tanzania, India, Mauritius, general corporate purposes and issue expenses. The only parent-level unutilised amount was Rs 1.697 crore for Nigerian capital expenditure, while the company reported no deviation or variation during the reporting half year.
The next disclosed matter to watch is the use of the Rs 1.697 crore balance for UMC Global Health Limited’s proposed expansion. Future utilisation disclosures can show whether the company continues to maintain the corresponding bank balance and when the remaining Nigerian allocation is deployed.


